Diligence Obligations. Bioeq shall use Commercially Reasonable Efforts to complete the ongoing Development of the Licensed Products in the Field in the Territory until receipt of Regulatory Approval for the Licensed Products in the Field in the Territory in accordance with and as set forth in a Development and Manufacturing plan (the Development & Manufacturing Plan). The initial Development & Manufacturing Plan is attached to this Agreement as [Schedule 3.2].

Diligence Obligations. Bioeq shall use Commercially Reasonable Efforts to obtain Regulatory Approval for the Licensed Products in the Field in the Territory in accordance with and as set forth in the Development & Manufacturing Plan.

Diligence Obligations. Licensee shall use Commercially Reasonable Efforts to Commercialize the Licensed Products in the Field in the Territory. In particular, Licensee commits to:

Diligence Obligations. On a Collaboration Target-by-Collaboration Target basis, following the License Effective Date with respect to the Licensed Development Candidate(s) Directed to such Collaboration Target, BMS shall use Commercially Reasonable Efforts # to Develop and to obtain Marketing Approval and, where applicable, Price Approval for ​ Directed to such Collaboration Target in each Major Market and # to Commercialize ​ in each Major Market following receipt of Marketing Approval.

Diligence Obligations. IMMEDICA shall itself, or through its Affiliates or Sublicensees, use Commercially Reasonable Efforts to Commercialize the Product in the Territory, including using Commercially Reasonable Efforts to perform the activities set forth under each Marketing Plan. All efforts of IMMEDICA’s Affiliates and Sublicensees will be considered efforts of IMMEDICA for the purpose of determining IMMEDICA’s compliance with its obligations under this Section 4.3.3.

Diligence Obligations. CANbridge, itself or through its Affiliates, Sublicensees, or subcontractors, will use Commercially Reasonable Efforts to Develop and seek Regulatory Approval for one Product directed to each Target in each of ​.

Diligence Obligations. Licensee will use commercially reasonable efforts to develop, commercialize, market, promote, and sell Licensed Products in the Field. Commercially reasonable efforts means efforts equivalent to those utilized by ​. Without limiting the foregoing, Licensee will meet the following: acceptance by the FDA or foreign equivalent of an investigational new drug application for a Licensed Product in the [[Unknown Identifier]] Field and [[Unknown Identifier]] Field by no later than​; provided, however, that, if Licensee expects not to achieve the milestone ​Certain information has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.

Diligence Obligations. LICENSEE shall be responsible for all Development and Commercialization activities with respect to the Products, and for all costs and expenses associated therewith, and shall use Commercially Reasonable Efforts to Develop and Commercialize a Product with respect to each Selected Gene in the Territory. LICENSEE shall, and shall use commercially reasonable efforts to cause its Affiliates and Sublicensees to, comply with all applicable Laws, including without limitation, obtaining all necessary licenses, permits and approvals in each region in the Territory where Commercialization activities occur.

Diligence Obligations. During the Term, Licensee will use Commercially Reasonable Efforts to # Develop the Licensed Compounds and Licensed Products in the Territory, including performing all obligations under and in accordance with the Development Plan, # file for, secure, and maintain Regulatory Approvals for Licensed Products in the Territory, and # Commercialize each Licensed Product in each country for which Regulatory Approval is obtained.

Commercialization Diligence Obligations. Following receipt of Regulatory Approval of a [[Unknown Identifier]] Co-Co Product in a Major Market within the Territory, each Party shall use Commercially Reasonable Efforts to perform, or cause to be performed, the activities for such [[Unknown Identifier]] Co-Co Product assigned to it in the applicable [[Unknown Identifier]] Co-Commercialization Plan in such Major Market and pursuant to this Agreement. Each Party shall conduct such activities in a good scientific manner, in accordance with GLP, GMP and GCP, as applicable, and in compliance with Applicable Laws.